C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 90,549 | N/A | N/A | N/A |
| Receivables | 4,623 | N/A | N/A | N/A |
| TOTAL | $96,767 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,463 | N/A | N/A | N/A |
| Other Non-Current Assets | 17,030 | 0 | 0 | 0 |
| TOTAL | $21,493 | $N/A | $N/A | $N/A |
| Total Assets | $118,260 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 5,385 | 0 | 0 | 0 |
| Accrued Expenses | 6,671 | N/A | N/A | N/A |
| TOTAL | $33,641 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 20,705 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 12,869 | 0 | 0 | 0 |
| TOTAL | $85,587 | $N/A | $N/A | $N/A |
| Total Liabilities | $119,228 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -117,488 | N/A | N/A | N/A |
| Other shareholders' equity | 110,995 | 0 | 0 | 0 |
| TOTAL | $-968 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $118,260 | $0 | $0 | $0 |